Comparison of multi-cancer early detection with LDCT in a lung cancer screening population
* Compare sensitivity and specificity of LDCT and GRAIL's MCED technology for detection of lung cancer across NLST and CCGA/PATHFINDER/SUMMIT study populations, controlling for cancer stage, size, and subtype and common demographic differences such as age, sex, smoking history, and self-reported ethnicity. Perform matching using generalized overlap weights [1], which are reported to have improved balancing properties compared to inverse propensity score weights.
* Estimate detection rate of non-lung cancers using GRAIL’s MCED technology in the high-risk NLST study population
[1] Li F, Thomas LE, Li F. Addressing extreme propensity scores via the overlap weights. American Journal of Epidemiology. 2019 Jan 1;188(1):250-7
John Beausang, GRAIL
Joerg Bredno, GRAIL
Geoff Stanley, GRAIL
Ellen Chang, GRAIL
Christina Clarke, GRAIL
Earl Hubbell, GRAIL
Zhaoyu Yin, GRAIL
Rita Lopatin, GRAIL
James Dai, GRAIL
Xinyi Hou, GRAIL
Bong Chul Chu, GRAIL